F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Nonalcoholic fatty liver disease

Page 1 of 5 ( 233 items )
<<
1
2
3
4
5
>>

1	Diagnostic accuracy of noninvasive steatosis biomarkers with magnetic resonance imaging proton density fat fraction as gold standard 5/26/2025 7:26:12 AM \| Browse: 8 \| Download: 35
2	Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations 3/26/2025 4:06:58 AM \| Browse: 23 \| Download: 39
3	Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen 3/26/2025 4:06:56 AM \| Browse: 22 \| Download: 31
4	What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? 12/30/2024 9:49:59 AM \| Browse: 54 \| Download: 115
5	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 62 \| Download: 220
6	Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology 11/29/2024 2:50:19 PM \| Browse: 70 \| Download: 322
7	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 66 \| Download: 282
8	Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future 10/31/2024 10:42:49 AM \| Browse: 62 \| Download: 206
9	Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis 10/25/2024 3:02:15 AM \| Browse: 72 \| Download: 210
10	Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis 7/17/2024 5:55:51 AM \| Browse: 94 \| Download: 309
11	Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 93 \| Download: 367
12	Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 93 \| Download: 279
13	Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study 6/20/2024 3:42:22 AM \| Browse: 148 \| Download: 399
14	Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 125 \| Download: 277
15	Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 129 \| Download: 255
16	Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions 4/12/2024 4:45:44 PM \| Browse: 143 \| Download: 306
17	Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis 3/27/2024 1:28:19 PM \| Browse: 156 \| Download: 477
18	Metabolic disease and the liver: A review 1/23/2024 9:31:45 AM \| Browse: 225 \| Download: 548
19	Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1 12/27/2023 5:42:53 AM \| Browse: 199 \| Download: 582
20	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 252 \| Download: 752
21	Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway 8/18/2023 10:08:22 AM \| Browse: 269 \| Download: 1005
22	Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value 6/25/2023 2:17:08 PM \| Browse: 250 \| Download: 672
23	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 262 \| Download: 699
24	Emerging role of engineered exosomes in nonalcoholic fatty liver disease 3/22/2023 11:20:34 AM \| Browse: 283 \| Download: 778
25	Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease 2/24/2023 1:35:50 PM \| Browse: 318 \| Download: 854
26	Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status 2/24/2023 1:35:50 PM \| Browse: 322 \| Download: 767
27	Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma 1/6/2023 2:52:58 AM \| Browse: 326 \| Download: 712
28	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 313 \| Download: 824
29	Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome 11/16/2022 11:26:06 AM \| Browse: 432 \| Download: 960
30	Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease 10/28/2022 7:46:25 AM \| Browse: 446 \| Download: 1137
31	Rare leptin in non-alcoholic fatty liver cirrhosis: A case report 9/27/2022 1:00:18 PM \| Browse: 353 \| Download: 1003
32	Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study 9/23/2022 12:48:56 AM \| Browse: 434 \| Download: 1217
33	Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease 9/15/2022 1:37:25 PM \| Browse: 445 \| Download: 1057
34	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 515 \| Download: 1121
35	Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 9/9/2022 12:48:14 PM \| Browse: 416 \| Download: 971
36	Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 441 \| Download: 861
37	Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 450 \| Download: 1122
38	Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives 7/18/2022 9:47:46 AM \| Browse: 521 \| Download: 1055
39	Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease 7/18/2022 9:47:46 AM \| Browse: 593 \| Download: 1412
40	Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases 7/13/2022 7:31:00 AM \| Browse: 387 \| Download: 1027
41	Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments 7/4/2022 12:30:52 PM \| Browse: 496 \| Download: 1739
42	Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus 6/23/2022 2:39:01 PM \| Browse: 442 \| Download: 1110
43	Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in children: A case report 6/17/2022 3:19:27 AM \| Browse: 444 \| Download: 1131
44	Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis 5/24/2022 10:35:19 AM \| Browse: 518 \| Download: 1191
45	Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities 5/18/2022 11:24:37 AM \| Browse: 477 \| Download: 1161
46	Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics 5/10/2022 9:43:36 AM \| Browse: 490 \| Download: 1062
47	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 476 \| Download: 1236
48	Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice 4/29/2022 6:42:52 AM \| Browse: 576 \| Download: 1891
49	Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B 4/22/2022 10:52:23 AM \| Browse: 481 \| Download: 1101
50	Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease 4/15/2022 8:25:28 AM \| Browse: 518 \| Download: 1715

Page 1 of 5 ( 233 items )
<<
1
2
3
4
5
>>

1	Diagnostic accuracy of noninvasive steatosis biomarkers with magnetic resonance imaging proton density fat fraction as gold standard 5/26/2025 7:26:12 AM \| Browse: 8 \| Download: 35
2	Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations 3/26/2025 4:06:58 AM \| Browse: 23 \| Download: 39
3	Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen 3/26/2025 4:06:56 AM \| Browse: 22 \| Download: 31
4	What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? 12/30/2024 9:49:59 AM \| Browse: 54 \| Download: 115
5	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 62 \| Download: 220
6	Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology 11/29/2024 2:50:19 PM \| Browse: 70 \| Download: 322
7	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 66 \| Download: 282
8	Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future 10/31/2024 10:42:49 AM \| Browse: 62 \| Download: 206
9	Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis 10/25/2024 3:02:15 AM \| Browse: 72 \| Download: 210
10	Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis 7/17/2024 5:55:51 AM \| Browse: 94 \| Download: 309
11	Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 93 \| Download: 367
12	Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 93 \| Download: 279
13	Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study 6/20/2024 3:42:22 AM \| Browse: 148 \| Download: 399
14	Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 125 \| Download: 277
15	Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 129 \| Download: 255
16	Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions 4/12/2024 4:45:44 PM \| Browse: 143 \| Download: 306
17	Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis 3/27/2024 1:28:19 PM \| Browse: 156 \| Download: 477
18	Metabolic disease and the liver: A review 1/23/2024 9:31:45 AM \| Browse: 225 \| Download: 548
19	Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1 12/27/2023 5:42:53 AM \| Browse: 199 \| Download: 582
20	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 252 \| Download: 752
21	Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway 8/18/2023 10:08:22 AM \| Browse: 269 \| Download: 1005
22	Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value 6/25/2023 2:17:08 PM \| Browse: 250 \| Download: 672
23	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 262 \| Download: 699
24	Emerging role of engineered exosomes in nonalcoholic fatty liver disease 3/22/2023 11:20:34 AM \| Browse: 283 \| Download: 778
25	Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease 2/24/2023 1:35:50 PM \| Browse: 318 \| Download: 854
26	Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status 2/24/2023 1:35:50 PM \| Browse: 322 \| Download: 767
27	Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma 1/6/2023 2:52:58 AM \| Browse: 326 \| Download: 712
28	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 313 \| Download: 824
29	Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome 11/16/2022 11:26:06 AM \| Browse: 432 \| Download: 960
30	Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease 10/28/2022 7:46:25 AM \| Browse: 446 \| Download: 1137
31	Rare leptin in non-alcoholic fatty liver cirrhosis: A case report 9/27/2022 1:00:18 PM \| Browse: 353 \| Download: 1003
32	Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study 9/23/2022 12:48:56 AM \| Browse: 434 \| Download: 1217
33	Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease 9/15/2022 1:37:25 PM \| Browse: 445 \| Download: 1057
34	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 515 \| Download: 1121
35	Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 9/9/2022 12:48:14 PM \| Browse: 416 \| Download: 971
36	Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 441 \| Download: 861
37	Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 450 \| Download: 1122
38	Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives 7/18/2022 9:47:46 AM \| Browse: 521 \| Download: 1055
39	Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease 7/18/2022 9:47:46 AM \| Browse: 593 \| Download: 1412
40	Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases 7/13/2022 7:31:00 AM \| Browse: 387 \| Download: 1027
41	Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments 7/4/2022 12:30:52 PM \| Browse: 496 \| Download: 1739
42	Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus 6/23/2022 2:39:01 PM \| Browse: 442 \| Download: 1110
43	Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in children: A case report 6/17/2022 3:19:27 AM \| Browse: 444 \| Download: 1131
44	Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis 5/24/2022 10:35:19 AM \| Browse: 518 \| Download: 1191
45	Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities 5/18/2022 11:24:37 AM \| Browse: 477 \| Download: 1161
46	Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics 5/10/2022 9:43:36 AM \| Browse: 490 \| Download: 1062
47	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 476 \| Download: 1236
48	Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice 4/29/2022 6:42:52 AM \| Browse: 576 \| Download: 1891
49	Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B 4/22/2022 10:52:23 AM \| Browse: 481 \| Download: 1101
50	Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease 4/15/2022 8:25:28 AM \| Browse: 518 \| Download: 1715